Filed Pursuant to Rule 424(b)(3)
Registration No. 333-276681
PROSPECTUS SUPPLEMENT NO. 1
(to prospectus dated
June 13, 2024)
THE BEACHBODY COMPANY, INC.
543,590 shares of Class A Common Stock
Issuable upon Exercise of Outstanding Warrants
This prospectus supplement is
being filed to update and supplement the information contained in the prospectus dated June 13, 2024 (the Prospectus), related to the resale from time to time, by the selling shareholders identified in the Prospectus under the
caption Selling Shareholders, of up to 543,590 shares of our Class A common stock, $0.0001 par value per share (the Class A Common Stock), of The Beachbody Company, Inc., a Delaware corporation (we,
us, our and similar terms), they may acquire upon the exercise of outstanding warrants, which we refer to as the Common Warrants, with the information contained in our Current Report on Form 8-K, filed with the Securities and Exchange Commission (SEC) on July 12, 2024 (the Information). Accordingly, we have attached the Information to this prospectus supplement.
This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except
in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this
prospectus supplement, you should rely on the information in this prospectus supplement.
Our shares of Class A Common Stock are listed on The New
York Stock Exchange under the symbol BODI. On July 11, 2024, the closing sale price per share of our Class A Common Stock was $8.50.
Investing in our securities
involves risks that are described in the Risk Factors section beginning on page 11 of the Prospectus. Neither the SEC nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or
determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is July 12, 2024.